tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Acumen Pharmaceuticals Inc

ABOS
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
2.130USD
-0.040-1.84%
์ข…๊ฐ€ย 07-24 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
153.84M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

ABOS ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Acumen Pharmaceuticals Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Acumen Pharmaceuticals Inc ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
May 12, 2026
EPS / ์˜ˆ์ƒ
-0.33/-0.40
์ˆ˜์ต / ์˜ˆ์ƒ
--/0.00
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
--
--
EPS(YoY)
-2.00
-17.50%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
STRONG BUY
2026/07/24
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
์žฌ๋ฌด ์ง€ํ‘œ
EPS
31.05%-0.33
32.89%-0.41
11.86%-0.44
-97.77%-0.68
-91.33%-0.48
-117.46%-0.62
-107.35%-0.50
-20.79%-0.34
9.78%-0.25
9.53%-0.28
---0.24
---0.28
---0.28
---0.31
---0.74
----
----
----
----
----
์ˆ˜์ต
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
์ˆœ์ด์ต
27.99%-20.74M
32.34%-25.14M
11.13%-26.45M
-99.40%-40.95M
-93.61%-28.80M
-125.22%-37.15M
-129.72%-29.77M
-76.89%-20.54M
-31.54%-14.87M
-28.22%-16.50M
-20.98%-12.96M
-14.37%-11.61M
-23.86%-11.31M
-54.10%-12.87M
-174.47%-10.71M
83.46%-10.15M
66.19%-9.13M
-1005.83%-8.35M
-56.71%-3.90M
-2915.14%-61.36M
๋ถ€์ฑ„๋น„์œจ
60.89%23.23%
106.09%25.37%
93.90%21.55%
70.95%17.38%
43.87%14.44%
24.54%12.31%
--11.11%
--10.17%
--10.04%
--9.88%
----
----
----
----
----
----
----
----
----
----
์ˆ˜์ต
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
์˜์—… ์ด์ต
30.36%-21.15M
36.36%-25.20M
17.83%-26.51M
-71.24%-41.75M
-70.87%-30.37M
-114.20%-39.60M
-101.17%-32.27M
-80.89%-24.38M
-35.32%-17.77M
-29.74%-18.49M
-41.05%-16.04M
-29.46%-13.48M
-42.68%-13.13M
-69.32%-14.25M
-188.97%-11.37M
-202.56%-10.41M
-142.71%-9.21M
-527.52%-8.41M
-58.03%-3.94M
-69.09%-3.44M
์ˆœ์ด์ต
27.99%-20.74M
32.34%-25.14M
11.13%-26.45M
-99.40%-40.95M
-93.61%-28.80M
-125.22%-37.15M
-129.72%-29.77M
-76.89%-20.54M
-31.54%-14.87M
-28.22%-16.50M
-20.98%-12.96M
-14.37%-11.61M
-23.86%-11.31M
-54.10%-12.87M
-174.47%-10.71M
83.46%-10.15M
66.19%-9.13M
-1005.83%-8.35M
-56.71%-3.90M
-2915.14%-61.36M
์œ ๋™์ž์‚ฐ
-14.10%133.09M
-31.44%122.25M
-36.35%132.15M
-44.40%148.40M
-39.43%154.95M
-27.70%178.31M
-5.02%207.63M
78.49%266.92M
77.62%255.83M
36.76%246.62M
7.92%218.60M
-21.73%149.54M
-25.02%144.03M
-9.23%180.33M
-1.15%202.56M
170.72%191.05M
356.26%192.10M
--198.66M
--204.91M
--70.57M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
51.33%29.23M
8.69%30.01M
10.25%21.96M
61.78%24.86M
127.99%19.32M
112.84%27.61M
226.57%19.91M
80.13%15.37M
-3.50%8.47M
66.04%12.97M
-7.79%6.10M
66.17%8.53M
123.04%8.78M
51.78%7.81M
344.12%6.61M
13.63%5.13M
-87.38%3.94M
--5.15M
--1.49M
--4.52M
์ด ์ž์‚ฐ
-34.65%133.63M
-48.60%122.83M
-46.73%142.22M
-40.50%171.90M
-32.06%204.48M
-22.94%238.99M
-6.77%266.98M
62.86%288.91M
60.20%300.97M
57.75%310.13M
40.89%286.37M
-16.19%177.41M
-14.64%187.86M
-14.65%196.59M
-13.45%203.26M
190.20%211.68M
419.40%220.09M
--230.33M
--234.85M
--72.94M
๋ถ€์ฑ„ ์ด๊ณ„
-5.73%46.15M
-8.35%52.40M
-1.46%49.05M
21.91%54.82M
25.75%48.96M
32.50%57.18M
716.22%49.77M
427.09%44.97M
343.48%38.93M
452.38%43.15M
-7.79%6.10M
65.36%8.53M
119.58%8.78M
51.78%7.81M
344.12%6.61M
14.19%5.16M
-87.18%4.00M
--5.15M
--1.49M
--4.52M
์ž๋ณธ ์ด๊ณ„
-43.75%87.48M
-61.26%70.43M
-57.10%93.17M
-52.01%117.08M
-40.65%155.52M
-31.90%181.82M
-22.50%217.20M
44.46%243.95M
46.32%262.03M
41.42%266.97M
42.52%280.27M
-18.23%168.87M
-17.12%179.09M
-16.17%188.78M
-15.73%196.65M
201.82%206.52M
1830.92%216.09M
--225.18M
--233.36M
--68.42M
์ˆœ์˜์—…์ด์ต
29.29%-24.13M
29.83%-19.10M
-23.96%-30.49M
-92.40%-31.83M
-91.06%-34.12M
-227.34%-27.21M
-90.59%-24.60M
-41.77%-16.55M
-75.52%-17.86M
25.79%-8.31M
-40.53%-12.90M
-80.43%-11.67M
-22.61%-10.18M
-207.86%-11.20M
-19.45%-9.18M
-51.69%-6.47M
-250.17%-8.30M
-27.37%-3.64M
-499.22%-7.69M
-185.41%-4.26M
์ˆœํˆฌ์ž
-148.13%-13.81M
-11.51%26.25M
499.83%40.51M
2.08%38.48M
411.74%28.69M
160.78%29.66M
88.99%-10.13M
240.74%37.70M
78.05%-9.20M
-139.02%-48.81M
-264.53%-92.00M
25.94%11.06M
-722.26%-41.93M
-103.98%-20.42M
159.42%55.92M
146516.67%8.79M
---5.10M
---10.01M
---94.10M
---6.00K
์ˆœ์žฌ๋ฌดํ™œ๋™
99383.33%35.74M
122.22%2.00K
100.00%0.00
100.00%0.00
-100.51%-36.00K
-100.03%-9.00K
-100.03%-42.00K
11.72%-128.00K
--7.11M
596.32%29.13M
46778.33%122.76M
-935.71%-145.00K
----
41740.00%4.18M
-100.16%-263.00K
-100.04%-14.00K
----
-99.98%10.00K
--168.78M
--31.68M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Acumen Pharmaceuticals Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Acumen Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 122.25M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -31.44์ž…๋‹ˆ๋‹ค.

Acumen Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Acumen Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Acumen Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ 122.83M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -48.60์ž…๋‹ˆ๋‹ค.

Acumen Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Acumen Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Acumen Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” 52.40M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -8.35์ž…๋‹ˆ๋‹ค.

Acumen Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Acumen Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Acumen Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ 70.43M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -61.26์ž…๋‹ˆ๋‹ค.

Acumen Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Acumen Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Acumen Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -123.83M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -8.61์ž…๋‹ˆ๋‹ค.

Acumen Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Acumen Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Acumen Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” 133.93M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 178.87์ž…๋‹ˆ๋‹ค.

Acumen Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Acumen Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Acumen Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ -34.00K์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -100.49์ž…๋‹ˆ๋‹ค.

Acumen Pharmaceuticals Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Acumen Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -2.00์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -17.50์ž…๋‹ˆ๋‹ค.

Acumen Pharmaceuticals Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Acumen Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -121.33M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -18.57์ž…๋‹ˆ๋‹ค.

Acumen Pharmaceuticals Inc์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Acumen Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 25.37์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 106.09์ž…๋‹ˆ๋‹ค.

Acumen Pharmaceuticals Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Acumen Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -96.20์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -110.96์ž…๋‹ˆ๋‹ค.

Acumen Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Acumen Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -67.07์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -79.95์ž…๋‹ˆ๋‹ค.

Acumen Pharmaceuticals Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Acumen Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -123.83M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -8.61์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ